Tempfer CB - Search Results

1

Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.

Hefler LA, Zeillinger R, Grimm C, Sood AK, Cheng WF, Gadducci A, Tempfer CB, Reinthaller A. Hefler LA, et al. Among authors: tempfer cb. Gynecol Oncol. 2006 Nov;103(2):512-7. doi: 10.1016/j.ygyno.2006.03.058. Epub 2006 Jun 5. Gynecol Oncol. 2006. PMID: 16750560

2

Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.

Lebrecht A, Ludwig E, Huber A, Klein M, Schneeberger C, Tempfer C, Koelbl H, Hefler L. Lebrecht A, et al. Gynecol Oncol. 2002 Apr;85(1):32-5. doi: 10.1006/gyno.2001.6517. Gynecol Oncol. 2002. PMID: 11925116

3

A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.

Six L, Grimm C, Leodolter S, Tempfer C, Zeillinger R, Sliutz G, Speiser P, Reinthaller A, Hefler LA. Six L, et al. Gynecol Oncol. 2006 Mar;100(3):506-10. doi: 10.1016/j.ygyno.2005.08.049. Epub 2005 Oct 6. Gynecol Oncol. 2006. PMID: 16214204

4

Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.

Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R. Hefler LA, et al. Clin Cancer Res. 2007 Feb 1;13(3):898-901. doi: 10.1158/1078-0432.CCR-06-1008. Clin Cancer Res. 2007. PMID: 17289883

5

The prohibitin 3' untranslated region polymorphism in patients with ovarian cancer.

Grimm C, Polterauer S, Zeillinger R, Tempfer C, Sliutz G, Reinthaller A, Hefler LA. Grimm C, et al. Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):236-9. doi: 10.1016/j.ejogrb.2007.04.010. Epub 2007 Jun 1. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 17544200

6

C-reactive protein is a prognostic parameter in patients with cervical cancer.

Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA. Polterauer S, et al. Gynecol Oncol. 2007 Oct;107(1):114-7. doi: 10.1016/j.ygyno.2007.06.001. Epub 2007 Jul 6. Gynecol Oncol. 2007. PMID: 17617445

7

Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer.

Polterauer S, Seebacher V, Hefler-Frischmuth K, Grimm C, Heinze G, Tempfer C, Reinthaller A, Hefler L. Polterauer S, et al. Am J Obstet Gynecol. 2009 Jun;200(6):647.e1-7. doi: 10.1016/j.ajog.2009.01.008. Am J Obstet Gynecol. 2009. PMID: 19306966

8

Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.

Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L. Polterauer S, et al. Oncologist. 2009 Oct;14(10):979-85. doi: 10.1634/theoncologist.2009-0079. Epub 2009 Sep 23. Oncologist. 2009. PMID: 19776095 Free article.

9

Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer.

Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB. Hefler LA, et al. Among authors: tempfer cb. Gynecol Oncol. 2002 Aug;86(2):134-7. doi: 10.1006/gyno.2002.6749. Gynecol Oncol. 2002. PMID: 12144818

10

Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.

Hefler LA, Ludwig E, Lebrecht A, Zeillinger R, Tong-Cacsire D, Koelbl H, Leodolter S, Tempfer CB. Hefler LA, et al. Among authors: tempfer cb. J Soc Gynecol Investig. 2002 Nov-Dec;9(6):386-90. J Soc Gynecol Investig. 2002. PMID: 12445604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters